These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 11148567

  • 1. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C, Megherat S, Vergnon I, Echchakir H, Dorothée G, Blesson S, Gay F, Mami-Chouaib F, Chouaib S.
    Cancer; 2001 Jan 01; 91(1):113-22. PubMed ID: 11148567
    [Abstract] [Full Text] [Related]

  • 2. Intratumoral induction of CD103 triggers tumor-specific CTL function and CCR5-dependent T-cell retention.
    Franciszkiewicz K, Le Floc'h A, Jalil A, Vigant F, Robert T, Vergnon I, Mackiewicz A, Benihoud K, Validire P, Chouaib S, Combadière C, Mami-Chouaib F.
    Cancer Res; 2009 Aug 01; 69(15):6249-55. PubMed ID: 19638592
    [Abstract] [Full Text] [Related]

  • 3. Engineered CD8+ cytotoxic T cells with fiber-modified adenovirus-mediated TNF-alpha gene transfection counteract immunosuppressive interleukin-10-secreting lung metastasis and solid tumors.
    Ye Z, Shi M, Chan T, Sas S, Xu S, Xiang J.
    Cancer Gene Ther; 2007 Jul 01; 14(7):661-75. PubMed ID: 17479109
    [Abstract] [Full Text] [Related]

  • 4. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector.
    Tanaka F, Abe M, Akiyoshi T, Nomura T, Sugimachi K, Kishimoto T, Suzuki T, Okada M.
    Cancer Res; 1997 Apr 01; 57(7):1335-43. PubMed ID: 9102222
    [Abstract] [Full Text] [Related]

  • 5. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice.
    Sabzevari H, Reisfeld RA.
    Cancer Res; 1993 Oct 15; 53(20):4933-7. PubMed ID: 8402683
    [Abstract] [Full Text] [Related]

  • 6. Human CD4+ effector T cells mediate indirect interleukin-12- and interferon-gamma-dependent suppression of autologous HLA-negative lung tumor xenografts in severe combined immunodeficient mice.
    Egilmez NK, Hess SD, Chen FA, Takita H, Conway TF, Bankert RB.
    Cancer Res; 2002 May 01; 62(9):2611-7. PubMed ID: 11980657
    [Abstract] [Full Text] [Related]

  • 7. Synergistic effect of intratumoral IL-12 and TNF-alpha microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells.
    Sabel MS, Arora A, Su G, Mathiowitz E, Reineke JJ, Chang AE.
    Surgery; 2007 Nov 01; 142(5):749-60. PubMed ID: 17981196
    [Abstract] [Full Text] [Related]

  • 8. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells.
    Saijo Y, Hong X, Tanaka M, Tazawa R, Liu SQ, Saijo K, Ohno T, Koike K, Ohkuda K, Satoh K, Nukiwa T.
    Clin Cancer Res; 1999 May 01; 5(5):1203-9. PubMed ID: 10353758
    [Abstract] [Full Text] [Related]

  • 9. Antitumor immune response of human peripheral blood lymphocytes coengrafted with tumor into severe combined immunodeficient mice.
    Iwanuma Y, Chen FA, Egilmez NK, Takita H, Bankert RB.
    Cancer Res; 1997 Jul 15; 57(14):2937-42. PubMed ID: 9230205
    [Abstract] [Full Text] [Related]

  • 10. A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence.
    Luo Y, Zhou H, Mizutani M, Mizutani N, Liu C, Xiang R, Reisfeld RA.
    Cancer Res; 2005 Apr 15; 65(8):3419-27. PubMed ID: 15833877
    [Abstract] [Full Text] [Related]

  • 11. Adoptive transfer of cytotoxic T-cells for treatment of residual disease after irradiation.
    Krause M, Schmitz M, Noessner E, Skrablin PS, Wehner R, Rieber EP, Baumann M.
    Int J Radiat Biol; 2007 Apr 15; 83(11-12):827-36. PubMed ID: 17852560
    [Abstract] [Full Text] [Related]

  • 12. T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function.
    Sharma S, Stolina M, Lin Y, Gardner B, Miller PW, Kronenberg M, Dubinett SM.
    J Immunol; 1999 Nov 01; 163(9):5020-8. PubMed ID: 10528207
    [Abstract] [Full Text] [Related]

  • 13. Redirected T-cell cytotoxicity to epithelial cell adhesion molecule-overexpressing adenocarcinomas by a novel recombinant antibody, E3Bi, in vitro and in an animal model.
    Ren-Heidenreich L, Davol PA, Kouttab NM, Elfenbein GJ, Lum LG.
    Cancer; 2004 Mar 01; 100(5):1095-103. PubMed ID: 14983507
    [Abstract] [Full Text] [Related]

  • 14. Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.
    Mogi S, Ebata T, Setoguchi Y, Fujime M, Heike Y, Kohsaka T, Yagita H, Okumura K, Azuma M.
    Clin Cancer Res; 1998 Mar 01; 4(3):713-20. PubMed ID: 9533541
    [Abstract] [Full Text] [Related]

  • 15. A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.
    So T, Takenoyama M, Ichiki Y, Mizukami M, So T, Hanagiri T, Sugio K, Yasumoto K.
    Cancer; 2005 Jan 01; 103(1):200-8. PubMed ID: 15573370
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
    Nakano H, Kishida T, Asada H, Shin-Ya M, Shinomiya T, Imanishi J, Shimada T, Nakai S, Takeuchi M, Hisa Y, Mazda O.
    J Gene Med; 2006 Jan 01; 8(1):90-9. PubMed ID: 16097036
    [Abstract] [Full Text] [Related]

  • 17. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression.
    Kataki A, Scheid P, Piet M, Marie B, Martinet N, Martinet Y, Vignaud JM.
    J Lab Clin Med; 2002 Nov 01; 140(5):320-8. PubMed ID: 12434133
    [Abstract] [Full Text] [Related]

  • 18. IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities.
    Ho MY, Leu SJ, Sun GH, Tao MH, Tang SJ, Sun KH.
    J Immunol; 2009 Nov 15; 183(10):6217-26. PubMed ID: 19841177
    [Abstract] [Full Text] [Related]

  • 19. Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production.
    Huang M, Sharma S, Mao JT, Dubinett SM.
    J Immunol; 1996 Dec 15; 157(12):5512-20. PubMed ID: 8955201
    [Abstract] [Full Text] [Related]

  • 20. Redirecting effector T cells through their IL-2 receptors.
    Lustgarten J, Marks J, Sherman LA.
    J Immunol; 1999 Jan 01; 162(1):359-65. PubMed ID: 9886407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.